Syntegon is expanding its pharmaceutical process and packaging technology business with the acquisition of Azbil Telstar. The companies want to jointly expand their growth opportunities and portfolios and offer solutions from a single source.
Telstar has an experienced team that serves customers in the pharmaceutical, life sciences and medtech sectors around the world, primarily in Southern and Western Europe, the USA and India. Freeze dryers and loading and unloading systems, including comprehensive services, are among the most important additions to the Syntegon portfolio for vial filling, including isolators. Freeze-drying, also known as lyophilisation, is a common process step for Long-term stability of drugs such as antibiotics, vaccines or biologics to guarantee the future. Telstar's business is characterised by its integration into the Syntegon Group with its complete solutions for pharmaceutical process and packaging technology.
„Syntegon is the global market leader in the filling of liquid pharmaceuticals in vials. With the acquisition of Telstar, we will expand our portfolio of innovative technologies and many successful references in the market. Our customers will benefit from even more comprehensive solutions, seamless processes and lifecycle services. At the same time, we can utilise growth opportunities together and expand our market presence.“
Torsten Türling, CEO of the Syntegon Group
With the expanded portfolio, Syntegon will offer both pharmaceutical manufacturers and contract manufacturing organisations (CMOs) even more opportunities. Better, seamless line solutions from a single source can offer. In addition, Syntegon will significantly expand its service network with Telstar's service technicians and further extend its geographical coverage, customer proximity and application expertise.
„Since the acquisition of Telstar in 2013, Azbil has expanded product capacity, particularly in the area of loading systems, and increased Telstar's overall competitiveness. Now Azbil has decided to transfer Telstar to the company that we believe is best suited to drive the business forward. We are convinced that Syntegon will optimally utilise the technological capabilities and products and achieve sustainable growth.“
Kiyohiro Yamamoto, President and Group CEO of Azbil
Telstar, headquartered in Terrassa (Barcelona), Spain, is a manufacturer and supplier of equipment for the global life science and healthcare industry. With approximately 900 employees, production facilities in Spain, China and the UK, and development, sales and service offices around the world, Telstar is a major player in the life science and healthcare industry. Addition to Syntegon's portfolio for the processing of liquid pharmaceuticals. Further growth opportunities will also arise for Telstar as part of the Syntegon Group. Syntegon and Azbil have agreed not to disclose financial details. The transaction is subject to regulatory approval.
„For Telstar, the integration into the Syntegon Group represents a great opportunity for stable business development and future growth. We look forward to bringing our experience, expertise and high-quality technologies for aseptic manufacturing to the joint portfolio and becoming part of the Syntegon team with a shared business and corporate culture.“
Jordi Puig, CEO of Telstar
Source: Syntegon
